AstraZeneca plc (LON:AZN) had its target price cut by equities research analysts at Nomura from GBX 4,880 ($70.23) to GBX 4,350 ($62.60) in a research report issued to clients and investors on Wednesday, Marketbeat reports. The firm presently has a “hold” rating on the biopharmaceutical company’s stock. Nomura’s price objective would suggest a potential upside […]
